Literature DB >> 14576328

Exploiting features of adenovirus replication to support mammalian kinase production.

Matt Cotten1, Kerstin Stegmueller, Jan Eickhoff, Miriam Hanke, Katrin Herzberger, Thomas Herget, Axel Choidas, Henrik Daub, Klaus Godl.   

Abstract

Faced with the current wealth of genomic data, it is essential to have robust and reliable methods of converting DNA sequences into their functional gene products. We demonstrate here that when conditions are established that take advantage of the replication-associated virus amplification, the virus-induced shutdown of host protein synthesis as well as the activation of signalling pathways that normally occur during virus replication, adenovirus biology can be exploited to generate a potent kinase expression system. Residual virus in the protein production has always been a limitation for adenovirus systems and we describe a DNA intercalator/ultraviolet light treatment that eliminates residual adenovirus in protein preparations that has no deleterious effect on enzyme activity. The use of mammalian cells in combination with adenovirus generated a variety of active enzymes which could not be produced in Escherichia coli or baculovirus-infected insect cells. Thus, the utility of adenovirus-mediated enzyme expression as a versatile alternative to established protein production technologies is demonstrated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576328      PMCID: PMC275485          DOI: 10.1093/nar/gng128

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  42 in total

Review 1.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Human adenovirus type 2 protein IIIa. I. Purification and characterization.

Authors:  P Lemay; M L Boudin; M Milleville; P Boulanger
Journal:  Virology       Date:  1980-02       Impact factor: 3.616

4.  Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10.

Authors:  Lee Anne Tibbles; Jason C L Spurrell; Gloria P Bowen; Qiang Liu; Mindy Lam; Anne K Zaiss; Stephen M Robbins; Morley D Hollenberg; Thomas J Wickham; Daniel A Muruve
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

5.  Transfer of genes into hematopoietic cells using recombinant DNA viruses.

Authors:  S Karlsson; R K Humphries; Y Gluzman; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

6.  MAP kinases and NF-kappaB collaborate to induce ICAM-1 gene expression in the early phase of adenovirus infection.

Authors:  Anna Tamanini; Rossella Rolfini; Elena Nicolis; Paola Melotti; Giulio Cabrini
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

7.  TNF-induced recruitment and activation of the IKK complex require Cdc37 and Hsp90.

Authors:  Guoqing Chen; Ping Cao; David V Goeddel
Journal:  Mol Cell       Date:  2002-02       Impact factor: 17.970

8.  Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function.

Authors:  Andrea D Basso; David B Solit; Gabriela Chiosis; Banabihari Giri; Philip Tsichlis; Neal Rosen
Journal:  J Biol Chem       Date:  2002-08-09       Impact factor: 5.157

9.  Control of cellular gene expression during adenovirus infection: induction and shut-off of dihydrofolate reductase gene expression by adenovirus type 2.

Authors:  S S Yoder; B L Robberson; E J Leys; A G Hook; M Al-Ubaidi; C Y Yeung; R E Kellems; S M Berget
Journal:  Mol Cell Biol       Date:  1983-05       Impact factor: 4.272

10.  Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells.

Authors:  N Jones; T Shenk
Journal:  Cell       Date:  1979-07       Impact factor: 41.582

View more
  2 in total

1.  An efficient proteomics method to identify the cellular targets of protein kinase inhibitors.

Authors:  Klaus Godl; Josef Wissing; Alexander Kurtenbach; Peter Habenberger; Stephanie Blencke; Heidrun Gutbrod; Kostadinos Salassidis; Matthias Stein-Gerlach; Andrea Missio; Matt Cotten; Henrik Daub
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-10       Impact factor: 11.205

2.  KSR1 is a functional protein kinase capable of serine autophosphorylation and direct phosphorylation of MEK1.

Authors:  Jeremy A Goettel; Dongchun Liang; Valda C Hilliard; Karen L Edelblum; Matthew R Broadus; Kathleen L Gould; Steven K Hanks; D Brent Polk
Journal:  Exp Cell Res       Date:  2010-12-07       Impact factor: 3.905

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.